Tag Archives: Goodbye

Pfizer’s Ibrance kisses early breast cancer hopes goodbye with second study failure

After Pfizer’s Ibrance failed a crucial study in HR-positive, HR-negative postsurgery breast cancer patients, the company clung to hope that it could still show a benefit in a high-risk subset of those patients. But new data have officially snuffed out those hopes. There’s “no saving adjuvant for Ibrance,” SVB Leerink analyst Geoffrey Porges wrote in… Read More »

Pain Management – Say Goodbye To Pain With Needles

Millions of people, including children, suffer from chronic pain. Pain management specialists are continuously looking for better ways to manage chronic pain. Even with the availability of various effective pain killers, pain management doctors prefer methods that use less medication because of the negative side effects that pain killers usually cause. This is true especially… Read More »